Research News

Generic antiretroviral drugs are a credible and cheaper alternative to brands

BMJ 2013; 346 doi: (Published 16 January 2013) Cite this as: BMJ 2013;346:f250


Switching from branded to generic antiretroviral drugs for adults with HIV could save the US government nearly $1bn (£0.62bn; €0.75bn) in the first year alone, according to an economic modelling study. Using a mathematical simulation of HIV, the authors compared the costs …

View Full Text

Sign in

Log in through your institution